// App-Quantinova.ai

Abstract 11459 : Mitochondrial Metabolites Predict Cardiovascular Outcomes and Heart Failure in Individuals with Type 2 Diabetes Mellitus: An Exscel Biomarker Substudy

Researchers

Presenter

  • Jessica A Regan

Principal Investigators

  • Robert J Mentz

  • Maggie Nguyen

  • Jennifer Green

  • Lauren Truby

  • Olga Ilkayeva

  • John Buse

  • Harald Sourij

  • David Sjostrom

  • Naveed Sattar

  • Adrian F Hernandez

  • Rury Holman

  • Svati H Shah

Medical Centers

  • Duke Hosp, Durham, NC

  • Univ of Oxford, Oxford, Ukraine

  • lndal, Sweden

  • DUKE UNIVERISTY, Durham, NC

  • Duke Medicine, Durham, NC

  • Graz

  • Duke Clinical Research Institute, Durham, NC

  • Duke Molecular Physiology Institute, Durham, NC

  • UNIVERSITY OF GLASGOW, Glasgow

  • DUKE UNIV MEDICAL CENTER, Hillsborough, NC

  • University of North Carolina, Chapel Hill, NC

Locations

  • United States

  • Ukraine

  • Sweden

  • Austria

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Coronary Artery Disease

  • Diabetes

  • Congestive heart failure

  • Stroke

Biomarkers

  • Hemoglobin A1c

  • Body mass index

Drug/Treatment

  • Sitagliptin

  • Exenatide

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved